![MESALAZOL suppositories MESALAZOL suppositories](https://www.farmaprim.md/img/p/2/7/3/273-large_default.jpg)
Composition:
Each suppository contains: mesalazine 250 mg or 500 mg, as active substance.
Therapeutic indication:
Used for treatment of inflammatory lesions (inflammatory bowel disease) of the rectum and distal colon.
Pharmacotherapeutic group and ATC code:
Intestinal antiinflammatory agents. Mesalazine. A07EC02.